CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $999,994
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$999,994. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-01-25 | Ciechanover Isaac E. Chief Executive Officer | Sale | −200 | $34.68 | $7K | 300,978 |
| 2018-01-24 | Ciechanover Isaac E. Chief Executive Officer | Sale | −8,100 | $33.20 | $269K | 317,278 |
| 2018-01-24 | Ciechanover Isaac E. Chief Executive Officer | Sale | −4,100 | $34.40 | $141K | 313,178 |
| 2018-01-24 | Ciechanover Isaac E. Chief Executive Officer | Sale | −2,200 | $34.99 | $77K | 310,978 |
| 2018-01-23 | Ciechanover Isaac E. Chief Executive Officer | Sale | −500 | $34.05 | $17K | 348,978 |
| 2018-01-23 | Ciechanover Isaac E. Chief Executive Officer | Sale | −15,084 | $35.45 | $535K | 333,894 |
| 2018-01-23 | Ciechanover Isaac E. Chief Executive Officer | Sale | −8,516 | $36.15 | $308K | 325,378 |
| 2018-01-22 | Ciechanover Isaac E. Chief Executive Officer | Sale | −500 | $30.93 | $15K | 358,978 |
| 2018-01-22 | Ciechanover Isaac E. Chief Executive Officer | Sale | −1,000 | $32.17 | $32K | 357,978 |
| 2018-01-22 | Ciechanover Isaac E. Chief Executive Officer | Sale | −6,500 | $33.08 | $215K | 351,478 |
| 2018-01-22 | Ciechanover Isaac E. Chief Executive Officer | Sale | −2,000 | $34.04 | $68K | 349,478 |
| 2018-01-16 | Ciechanover Isaac E. Chief Executive Officer | Sale | −600 | $30.38 | $18K | 359,478 |
| 2018-01-12 | MCGRATH JOHN EVP & Chief Financial Officer | Option exercise | +30,000 | $11.00 | $330K | 123,154 |
| 2018-01-12 | MCGRATH JOHN EVP & Chief Financial Officer | Sale | −3,500 | $22.32 | $78K | 119,654 |
| 2018-01-12 | MCGRATH JOHN EVP & Chief Financial Officer | Sale | −30,000 | $25.00 | $750K | 89,654 |
| 2018-01-12 | MCGRATH JOHN EVP & Chief Financial Officer | Option exercise · Employee Stock Option (Right to Buy) | −30,000 | 10,000 | ||
| 2018-01-12 | Ciechanover Isaac E. Chief Executive Officer | Sale | −100 | $30.05 | $3K | 360,078 |
| 2018-01-11 | MCGRATH JOHN EVP & Chief Financial Officer | Sale | −3,500 | $20.77 | $73K | 93,154 |
| 2018-01-11 | Ciechanover Isaac E. Chief Executive Officer | Sale | −2,500 | $21.49 | $54K | 377,678 |
| 2018-01-11 | Ciechanover Isaac E. Chief Executive Officer | Sale | −17,500 | $22.01 | $385K | 360,178 |
Page 38 of 44 · 867 trades